Mechanisms of Skeletal Stem Cell Aging
Mechanisms of Skeletal Stem Cell Aging
批准号:
9780833
负责人:
Charles KF Chan
金额:
$24.9万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-09-30 至 2021-05-31
关键词:
AffectAgeAgingAreaAtherosclerosisAtrophic condition of skinAwardBiological AssayBiology of AgingBone DensityBone DiseasesBone ResorptionCartilageCause of DeathCell AgingCell LineageCellsDataDefectDegenerative polyarthritisDependenceDeteriorationDiseaseDysmyelopoietic SyndromesElderlyEndocrine systemEnvironmentFractureFrequenciesGenerationsGenesGeneticHematopoieticHematopoietic stem cellsHip FracturesHomeostasisImpairmentIn VitroIncidenceIndividualInfectionInfertilityInjuryIonsKyphosis deformity of spineLeadLentivirus VectorLightLimb structureLinkLongevityMarrowMeasuresMedicalMetabolismMineralsModelingMorbidity - disease rateMusMuscular AtrophyMyelogenousNeonatalOperative Surgical ProceduresOsteoclastsOsteopeniaOsteoporosisParabiosisPatientsPhasePhenotypePlayPopulationPositioning AttributeProcessProductionPulmonary EmphysemaRegulationResolutionRoleSerumSkeletal systemSkeletonStem cellsStromal CellsSurfaceSystemT-LymphocyteTestingTherapeuticTissuesTransplantationVitamin Dage effectage groupage relatedagedbonebone turnovercalcificationchronic painclinically translatabledisabilityeditorialexperimental studyfallshealingimplantationin vivonovelorgan regenerationprogenitorprospectivepublic health relevanceregenerativeresponse to injuryskeletalskeletal disordersoft tissuestem cell nichestem cell populationtranscriptome
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Among the diseases and disorders associated with advancing age, one of the most debilitating is the loss of normal homeostatic function of the skeleton. This is particularly true with osteoporosis, wherein hip fractures are invariably associated with chronic pain, reduced mobility, disability, and an increased degree of dependence. In addition, up to 20% of patients die within the first year following hip fractures. Less than half of those who survive the hip fracture regain their previous level of function. As th world's population is continuing to age at a rapid rate, the incidence of skeletal disease is expected to rise substantially. Current medical and surgical therapies for age-related bone disease are suboptimal, the majority relying on the implantation of foreign materials that are subject to a host of complications including infection and further fractures. For this reason, we are focusing on the stem cell population within bone as a potential target to understand and harness the body's intrinsic potential to heal disorders of the skeleton. Stem cells are the cells that are responsible for maintaining normal homeostasis in an organ, and for regeneration following injury. We have identified a skeletal stem cell population which is capable of forming all of the components of the skeleton - bone, cartilage and the marrow stroma. It is proposed that the reduced regenerative capacity that occurs with aging is a multifaceted problem, perhaps due to intrinsic changes in the stem cells themselves or changes in the environment in which the cells reside - the stem cell "niche", or perhaps a combination of these. Our first aim is to characterize the effects of aging on normal bone homeostasis in young and old mice, exploring parameters such as bone turnover and bone mineral density. We have devised a novel injury model to identify age-related differences in response to injury. With this data we will then look a the role of the systemic environment on the skeletal system, specifically exploring the role of the
niche in maintaining an efficient pool of skeletal stem cells using a heterochronic parabiosis model where a young and an old mouse will be surgically paired. This study will allow for identification of novel mechanisms responsible for skeletal aging and will allow for identification
of clinically-translatable ways of harnessing the intrinsic regenerative potential of stem cells in
the skeleton system to reduce the biomedical burden currently associated with age-related skeletal disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Acquisition of A Microfluidic Chip-Based System for Cluster Sorting and Dispensing
-
批准号:10177766
-
项目类别:
-
资助金额:$46.87万
-
财政年份:2021
-
负责人:Charles KF Chan
-
依托单位:
Mechanisms of Skeletal Stem Cell Aging
-
批准号:9975664
-
项目类别:
-
资助金额:$24.9万
-
财政年份:2018
-
负责人:Charles KF Chan
-
依托单位:
Mechanisms of Skeletal Stem Cell Aging
-
批准号:9789789
-
项目类别:
-
资助金额:$24.9万
-
财政年份:2018
-
负责人:Charles KF Chan
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: